glp 1 pregnancy category Q&A: Providers need to shift course with diabetes medications, technology during Use of GLP1 receptor agonists

Stefan Cimbollek has received educational sponsorships, speaker fees, and participated in advisory boards and travel grants from Novartis, Pharming, Takeda, CSL Behring, and Biocryst, and participated in clinical trials sponsored by Novartis, Jerini/Shire, CSL Behring, Pharming, and Ionis

Nature, 2014

All mice were maintained on a 12-hour light/dark cycle under specific pathogen-free conditions, with free access to sterile water and irradiated food

Therefore, heparin binding by apo-HPX at acidic pH in vitro likely represents an interaction between apo-HPX and a membrane-associated HSPG in vivo rather than an effect on heme binding to HPX because absorbance spectroscopy of ligand binding to hemopexin showed that heme competed effectively with heparin (80-fold molar excess) for HPX binding (Figure 8D)